Gene Therapy - Publications - Faculty & Research

18 Jul 2024
Blog Post

Harvard Business School Announces Its 2024-2025 Blavatnik Fellows

immune system-driven dendritic cell therapy to combat cancer, new molecular technologies for the delivery of transdermal formulations, a lipid-targeting drug to treat cancer and neurodegenerative disorders, and AI-driven medical... View Details

29 Jun 2022
Blog Post

Harvard Business School Announces the 2022-2023 Blavatnik Fellows

Harvard-affiliated postdocs as they build their promising life science ventures by developing their leadership talents and providing mentorship and community during their entrepreneurial journey. To date, Blavatnik Fellows have created 30 companies including a... View Details

21 Mar 2022
Blog Post

The Impact of Career Coaching | When Mission Meets Passion

evaluating hearing healthcare investments. For example, I recently advised a company developing gene therapies for hearing loss. For the engagement, we delivered strategic recommendations for clinical trial... View Details

03 Mar 2017
News

Big Blue’s Big Bet

myeloid leukemia, a blood cancer in which abnormal white blood cells grow quickly. They comforted her by saying that the chemotherapy they were prescribing would attack the abnormal cells. And it did. But her recovery from post-remission View Details

Keywords: Paul Kix; illustrations by Dan Page

14 Aug 2018
First Look

First Look at New Research and Ideas, August 14, 2018

decide how to bring Elyas on board, and ensure a robust strategy to maintain its leadership position in the region. Purchase this case: https://hbsp.harvard.edu/product/818022-PDF-ENG Harvard Business School Case 818-059 Spark Therapeutics: Pioneering View Details

Keywords: by Sean Silverthorne

22 Nov 2016
First Look

November 22, 2016

commercial implications—the technology would be immensely important to biotechnology firms looking to develop gene therapy products and was, therefore, sure to generate strong revenues for whichever entity... View Details

Keywords: Sean Silverthorne

10 Jan 2012
First Look

First Look: January 10

MaterialsOral Rehydration Therapy Nava Ashraf and Claire QureshiHarvard Business School Case 911-035 This case highlights the puzzlingly high rate of diarrhea-related child mortality in developing countries despite the existence of a... View Details